276 related articles for article (PubMed ID: 12522895)
21. Follow-up of differentiated thyroid cancer.
Pacini F
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
[TBL] [Abstract][Full Text] [Related]
22. Metastatic thyroid carcinoma of the adrenal gland.
Girelli ME; Casara D; Rubello D; Piccolo M; Piotto A; Pelizzo MR; Busnardo B
J Endocrinol Invest; 1993 Feb; 16(2):139-41. PubMed ID: 8463550
[TBL] [Abstract][Full Text] [Related]
23. Adrenal and renal metastases from follicular thyroid cancer.
Kumar A; Nadig M; Patra V; Srivastava DN; Verma K; Bal CS
Br J Radiol; 2005 Nov; 78(935):1038-41. PubMed ID: 16249606
[TBL] [Abstract][Full Text] [Related]
24. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
25. Tumor-to-tumor metastases: papillary thyroid carcinoma into a clear cell renal cell carcinoma.
Song JS; Taylor SM; Trites J; Rigby MH; Bullock MJ; Merrimen J; Rendon R; Hart RD
J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):17. PubMed ID: 28249616
[TBL] [Abstract][Full Text] [Related]
26. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
27. Renal metastasis from papillary thyroid microcarcinoma.
Liou MJ; Lin JD; Chung MH; Liau CT; Hsueh C
Acta Otolaryngol; 2005 Apr; 125(4):438-42. PubMed ID: 15823819
[TBL] [Abstract][Full Text] [Related]
28. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
[TBL] [Abstract][Full Text] [Related]
29. Unusual Adrenal and Brain Metastases From Follicular Thyroid Carcinoma Revealed by 131I SPECT/CT.
Zhao Z; Shen GH; Liu B; Kuang AR
Clin Nucl Med; 2016 Jan; 41(1):e53-5. PubMed ID: 26018699
[TBL] [Abstract][Full Text] [Related]
30. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
[TBL] [Abstract][Full Text] [Related]
31. Occult distant metastases of well-differentiated thyroid carcinoma.
Zohar Y; Strauss M
Head Neck; 1994; 16(5):438-42. PubMed ID: 7960741
[TBL] [Abstract][Full Text] [Related]
32. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.
Gezer E; Selek A; Tarkun İ; Cantürk Z; Çetinarslan B
J Med Case Rep; 2019 Apr; 13(1):95. PubMed ID: 31003598
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830
[TBL] [Abstract][Full Text] [Related]
35. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
36. [Clinical picture of differentiated thyroid carcinoma in the T1 stage].
Czarniecka A; Włoch J; Lange D
Wiad Lek; 2001; 54 Suppl 1():225-33. PubMed ID: 12182030
[TBL] [Abstract][Full Text] [Related]
37. Synchronous colon cancer with pulmonary metastasis and follicular variant of papillary thyroid cancer metastasising to kidney.
Kadamkulam Syriac A; Mirza M; Malekunnel AR; Locante A; Desai P
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30093473
[TBL] [Abstract][Full Text] [Related]
38. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
39. [Outcome in cervical recurrences of papillary or follicular thyroid cancer].
Mirallié E; Hamy A; Floch I; Sagan C; Paineau J; Murat A; Le Néel JC; Visset J
Ann Chir; 1999; 53(7):577-82. PubMed ID: 10520496
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]